ArticleCureus2026
A Presumed Metastatic Lung Lesion Unveiling a Second Primary: Renal Cell Carcinoma With Coinciding Invasive Mucinous Adenocarcinoma.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple primary cancer is a self-explanatory term, albeit very uncommon. In most instances, when patients have a malignancy, the possibility of metastasis should be considered. Renal cell carcinoma (RCC) is one such cancer. However, as unlikely as it is, there is always a chance that another separate, unrelated malignancy could be present. Here, we would like to discuss a unique case of a 66-year-old female who not only developed primary RCC but also primary invasive mucinous adenocarcinoma of the lung. This revelation prompted a change in management, resulting in the medical team treating the two malignancies separately via surgical intent as opposed to treating metastatic RCC, which is more geared toward systemic medical therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.